Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028247 · ClinicalTrials.gov registry record · NA
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
A NA study of Autism and Obsessive - Compulsive Disorder, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 1
- Study location
NCT02028247: Completed NA study of Autism and Obsessive - Compulsive Disorder, sponsored by University of South Florida.
NCT02028247 is a NA study of Autism and Obsessive - Compulsive Disorder that has completed, run by University of South Florida. The registered enrollment target is 214 participants, above the 181-participant average among 104 other Autism trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02028247, a NA study of Autism and Obsessive - Compulsive Disorder, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth with ASD.
Primary Outcome
This measure is administered by a clinician and assesses anxiety symptom severity on a scale from 0-25 with higher scores corresponding to worse anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Personalized Cognitive-behavioral therapy
- BEHAVIORAL Standard Practice Cognitive-behavioral therapy
Study Locations (1)
Florida
- Rothman Center for Neuropsychiatry, University of South Florida - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02028247 record still lists
NCT02028247 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 104 other Autism trials with a reported enrollment target (18% higher).
The record links to 9 conditions, with Autism appearing as the primary indexed condition, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT02028247 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02028247 about?
NCT02028247 is a clinical study titled "Psychotherapy for Anxiety in Children With Autism Spectrum Disorder". Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth...
What is the current status of trial NCT02028247?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2014-04. Estimated completion is 2018-10.
What conditions does trial NCT02028247 study?
This clinical trial studies the following conditions: Autism, Obsessive - Compulsive Disorder, Generalized Anxiety Disorder, Autism Spectrum Disorders, Social Phobia.
What interventions are being tested in trial NCT02028247?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Personalized Cognitive-behavioral therapy (BEHAVIORAL), Standard Practice Cognitive-behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02028247?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02028247 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02028247's enrollment target sits among peer trials
214 19th of 104 higher than 86 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia